House Bill Seeks To Restore 50% Orphan Drug Tax Credit
By Theresa Schliep · March 31, 2020, 5:54 PM EDT
A bill recently introduced in the U.S. House of Representatives would increase a tax credit for pharmaceutical companies developing treatments for rare diseases to 50%, its level before the 2017 federal...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login